Inflammation-Related Factors S100A9 and TLR2 in Cardiomyocyte Hypertrophy
- PMID: 40694254
- DOI: 10.1007/s11596-025-00096-2
Inflammation-Related Factors S100A9 and TLR2 in Cardiomyocyte Hypertrophy
Abstract
Objective: The pathogenesis and progression of heart failure (HF) are governed by complex, interconnected biological pathways, with dysregulated immune responses and maladaptive cardiac remodeling playing central roles. Although specific inflammatory mediators have been implicated in modulating critical features of cardiac remodeling-such as cardiomyocyte hypertrophy and extracellular matrix fibrosis-the precise molecular mechanisms driving these processes remain incompletely characterized.
Methods: Integrated bioinformatics analysis of HF and hypertrophic cardiomyopathy (HCM) transcriptomic datasets identified pathologically relevant candidate genes. A protein-protein interaction (PPI) network was constructed from these candidates using the STRING database, followed by module analysis. Serum S100 calcium-binding protein A9 (S100A9) protein expression in HF patients was quantified by Western blotting under reducing conditions. The functional relevance of prioritized genes was subsequently validated through: (i) in vitro cyclic mechanical stretch in primary neonatal rat cardiomyocytes, and (ii) in vivo pressure overload modeling via transverse aortic constriction (TAC) in mice.
Results: Bioinformatics analysis of HF and HCM datasets revealed a significant association between immune function and cardiac remodeling. Using CytoNCA, we identified core genes, among which the top 25 included multiple inflammatory pathway-related factors, such as S100A9 and Toll-like receptor 2 (TLR2). Notably, S100A9 levels were significantly elevated in the serum of HF patients and in mechanically stretched cardiomyocytes. This increase correlated with upregulated expression of hypertrophy-related markers, including atrial natriuretic peptide (ANP). Furthermore, mechanical stretch-induced S100A9 upregulation markedly enhanced TLR2 expression in cardiomyocytes. Importantly, TLR2 inhibition substantially attenuated the mechanical stretch-induced upregulation of S100A9 mRNA expression, as well as the subsequent hypertrophic and inflammatory responses in cardiomyocytes.
Conclusion: The inflammatory mediators S100A9 and TLR2 engage in reciprocal activation that amplifies the hypertrophic response in mechanically stretched cardiomyocytes. This pathogenic cross-talk exacerbates maladaptive remodeling and likely accelerates HF progression.
Keywords: Cardiomyocyte hepertrophy; Heart failure; Inflammatory response; Mechanical stretch; Reciprocal activation; S100 calcium-binding protein A9; Toll-like receptor 2; Transverse aortic constriction.
© 2025. The Author(s), under exclusive licence to Huazhong University of Science and Technology.
Conflict of interest statement
Declarations. Competing Interests: The authors declare no competing interests. Ethical Approval and Consent to Participate: All experimental protocols involving animals in this study were approved by the Animal Care and Use Committee of Zhongshan Hospital, Fudan University. All the human studies were approved by the ethics committee of Zhongshan Hospital, Fudan University (Approval No: B2021-886R). Consent for Publication: Not applicable.
Similar articles
-
Single-cell RNA sequencing reveals that myeloid S100A8/A9 is a novel regulator of the transition from adaptive hypertrophy to heart failure after pressure overload.Theranostics. 2025 Jul 28;15(16):8587-8608. doi: 10.7150/thno.118369. eCollection 2025. Theranostics. 2025. PMID: 40860162 Free PMC article.
-
Cardiac-specific overexpression of PRMT5 exacerbates pressure overload-induced hypertrophy and heart failure.J Biomed Sci. 2025 Jul 6;32(1):61. doi: 10.1186/s12929-025-01162-6. J Biomed Sci. 2025. PMID: 40619438 Free PMC article.
-
Pyruvate Dehydrogenase Kinase 4 Underlies the Metabolic Disorder of Cardiomyocytes in Patients With Hypertrophic Cardiomyopathy From Hypertrophy to Heart Failure.J Am Heart Assoc. 2025 Aug 5;14(15):e041401. doi: 10.1161/JAHA.125.041401. Epub 2025 Jul 29. J Am Heart Assoc. 2025. PMID: 40728184
-
Piezo1 in heart failure: A new perspective from cytomechanical sensing to diverse cellular pathways.Mol Biol Rep. 2025 Sep 3;52(1):862. doi: 10.1007/s11033-025-10969-3. Mol Biol Rep. 2025. PMID: 40900224 Review.
-
Matrisome remodeling in the myocardium of hypertrophic cardiomyopathy; novel targets for molecular diagnostics.Front Cell Dev Biol. 2025 Aug 6;13:1641584. doi: 10.3389/fcell.2025.1641584. eCollection 2025. Front Cell Dev Biol. 2025. PMID: 40843168 Free PMC article. Review.
References
-
- Chen F, He Z, Wang C, et al. Advances in the study of S100A9 in cardiovascular diseases. Cell prolif. 2024:e13636.
-
- Lu H, Wang J, Chen Z, et al. Engineered Macrophage Membrane-Coated S100A9-siRNA for Ameliorating Myocardial Ischemia-Reperfusion Injury. Adv Sci (Weinh). 2024;11(41):e2403542. - PubMed
-
- Li Y, Chen B, Yang X, et al. S100a8/a9 Signaling Causes Mitochondrial Dysfunction and Cardiomyocyte Death in Response to Ischemic/Reperfusion Injury. Circulation. 2019;140(9):751–764. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous